申请人:Exelixis, Inc.
                            
                            
                                公开号:US20170217896A1
                            
                            
                                公开(公告)日:2017-08-03
                            
                            The present invention relates to a method of preparing Cabozantinib (Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenylo]amide(4-fluoro-phenyl)amide) and
18
F labeled Cabozantinib.